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Abstract
It is currently possible to visualize structural alterations with a size of only 2–3 mmwith endoscopic ultrasound. For clinical
work it is important to differentiate between adenoma and metastatic adrenal tumors, especially in those patients with
cancer or a history of treated cancer. Solitary adrenal metastasis is often difﬁcult to distinguish from benign adrenal
adenoma. In this clinical situation, EUS-guided FNA of the adrenal glands is a minimally invasive and safe approach that
documents or excludes malignant involvement. This article is part of an expert video encyclopedia.
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Video Related to this Article
Materials
• Radial echoendoscopes (EG-3670 URK; Pentax Europe
GmbH, Hamburg, Germany) or longitudinal echoendo-
scopes (EG-3870 UTK; Pentax Europe GmbH, Hamburg,
Germany; UCT 140-AL5; Olympus Medical Systems Europe
GmbH, Hamburg, Germany).
• Fine needles for endoscopic ultrasound (25 gauge, 22
gauge, 19 gauge; Cook Medical, Bloomington, USA; Med-
iglobe, Achenmu¨hle, Germany; Olympus Medical, Ham-
burg, Germany; Boston Scientiﬁc, Natick, MA, USA).
• High-end ultrasound platforms (HI Vision Preirus, Hitachi
Medical Systems, Wiesbaden, Germany; Pro Sound Alpha
5, ALOKA GmbH, Willich, Germany).
Background and Endoscopic Procedure
Different sonomorphological masses can be distinguished in
the region of the adrenal glands. Hyperechogenic lesions are
rare. As in the kidney, these lesions often represent myolipo-
mas, lipomas, and angiomyolipomas, which usually have a
smooth contour (or border).1 Inhomogeneities and calciﬁca-
tions can occur, depending on the size of the lesion. Very rare
ﬁndings are cystic lesions. Differential diagnoses are pseudo-
cysts of the pancreatic tail or renal cysts, or – very rarely –
cystic tumors of the adrenal gland.
The list of cystic tumors include:
• Cystic pheochromocytomas.
• Cystic lymphangioma.
• Adrenal hydatid cysts.
Adrenal (gland) masses with low, medium, or mixed
echogenicity are signiﬁcantly more common than anechoic or
homogeneous echogenic lesions. This is a heterogeneous
group of tumors with varying clinical relevance. Adrenocor-
tical adenomas are typically relatively small, smooth-
contoured, round or oval, and homogeneous and hypoechoic
tumors which can interrupt or suppress the midline echo.
They have been identiﬁed in 2–8% of autopsy studies.
Pheochromocytomas are typically larger than adrenal
gland adenomas. Due to regressive changes and bleeding,
large pheochromocytomas typically exhibit structural inho-
mogeneities.2,3 Cystic pheochromocytomas are a rare variant
of pheochromocytomas.4 Cystic degeneration occurs as the
tumor increases in size and outgrows its vascular supply.
The characteristic features of pheochromocytomas are:
• Frequency 0.13% (autopsy).
• 3–9% of incidentally discovered adrenal gland tumors.
• Size-related structural inhomogeneities.
• Rarely hyperechoic.
• Typically hypervascular.
• Also large avascular areas.
Primary adrenal gland carcinomas are very rare but can
reach signiﬁcant size. Typically they inﬁltrate neighboring
structures.
Metastases usually appear as hypoechoic tumors. Typical
features are irregular contours, inhomogeneity, loss of normal
adrenal gland anatomy, and inﬁltration into adjacent organs.
Adrenal glands are a predilection site for metastatic spread in
patients with lung cancer. However, also gastrointestinal and
pancreatobiliary cancer, breast cancer, renal cancer, and
melanoma are reported to metastasize into the adrenal glands.
This article is part of an expert video encyclopedia. Click here for the full
Table of Contents.
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In general, adrenal glands are the fourth most common site of
metastases in malignant disease. Approximately 4–7% of pa-
tients with otherwise operable non-small-cell lung cancer
present with a unilateral adrenal mass. As up to 50% of ad-
renal masses in patients with nonsmall cell lung cancer rep-
resent benign adenomas, tissue veriﬁcation of suspected
malignant involvement is essential. Therefore, EUS-FNA
qualiﬁes as the staging test of choice for patients with lung
cancer and other malignant tumors with suspected left
adrenal metastases.5 EUS-FNA of the right adrenal masses is
also feasible and may be an alternative to percutaneous
sampling.6
The list of hypoechoic adrenal tumors include:7
• Primary adrenal gland tumor.
• Metastases.
• Lymphoma.
• Mesenchymal tumor.
• Differential diagnosis: primary renal tumor and pancreatic
tail tumor.
Contrast-enhanced (endoscopic) ultrasound is suitable for
determining the vascularization of the adrenal gland masses,
but is rarely helpful in the differentiation between benign and
malignant mass lesions.8,9 With the exception of inﬁltrating
growth and regional lymph node metastases, there are no re-
liable (endoscopic) ultrasound criteria for differentiating be-
tween hypoechoic benign and malignant adrenal gland
tumors.10–12
Key Learning Points
• Adrenal gland mass lesions with low, medium, or mixed
echogenicity are signiﬁcantly more common than anechoic
or homogeneous echogenic lesions.
• Solitary adrenal metastases are often difﬁcult to distinguish
from benign adrenal tumors.
• Primary adrenal gland carcinomas are very rare but can
reach signiﬁcant size.
• Pheochromocytomas are typically larger than adrenal
gland adenomas; due to regressive changes, heterogeneity
and cystic appearance are typical features.
• Contrast-enhanced (endoscopic) ultrasound is suitable for
determining the vascularization of the adrenal gland mass
lesion.
• EUS-FNA of an enlarged adrenal gland in patients with
known or suspected cancer has a signiﬁcant impact of TNM
staging.
Complications and Risk Factors
EUS-guided FNA of the adrenal glands is a minimally invasive
and safe approach to tissue diagnosis.13,14 Conversely, per-
cutaneous biopsy of the adrenal glands is reported to have a
complication rate of 2.8–8.4%.15,16
Scripted Voiceover
Time
(min:sec)
Voiceover text
00:03–00:10 This short video sequence shows the normal left
adrenal gland as a reminder.
00:10–00:30 We can distinguish different sonomorphological
types of mass forming lesions in the region of the
adrenal glands. Hyperechogenic adrenal gland
mass lesions are rare and in most cases represent
angiomyolipoma.
00:31–00:36 This is a lung cancer metastasis to the left adrenal
gland.
00:37–00:56 For daily clinical work it is most important to
differentiate between adenoma and metastatic
adrenal tumors. Other mass forming lesions like
primary adrenal carcinoma, pheochromocytoma
and lymphoma are rare.
00:57–01:04 This is another example for a metastasis of lung
cancer.
01:05–01:24 Besides adrenal adenomas metastases are most
common in hypoechoic adrenal gland tumors.
Adrenal glands are a predilection site for
metastatic spread in patients with lung cancer.
01:25–01:32 A metastasis of the left adrenal gland.
01:33–01:40 In up to 50% of cases metastases are found
bilaterally.
01:41–01:59 EUS-guided ﬁne-needle aspiration (FNA) of the
adrenal glands is a minimally invasive and safe
approach that proves or excludes malignant
involvement with high accuracy.
02:00–02:11 Tumors of the right adrenal gland are better
visualized using transabdominal ultrasound.
02:12–02:23 Solitary adrenal metastasis is often difﬁcult to
distinguish from benign adrenal tumor.
02:24–02:31 This is a non-functional adenoma.
02:32–02:43 Autopsy reveals adrenal metastases in up to 27% of
patients with malignant diseases.
02:44–02:55 EUS-FNA of a metastasis in a patient with non-small
cell lung cancer.
02:56–03:11 4–7% of patients with otherwise operable non-
small cell lung cancer (NSCLC) present with a
unilateral adrenal metastasis.
03:12–03:43 As up to 50% of adrenal masses in patients with
NSCLC represent benign adenomas, tissue
veriﬁcation of suspected malignant involvement is
essential. Therefore, EUS-FNA is the staging test
of choice for patients with lung cancer and other
malignant tumors with suspected left adrenal
metastases.
03:44–03:56 This is an inhomogeneous tumor in a patient with
pancreatic cancer. EUS-FNA is inevitable to give
evidence of metastatic disease.
03:57–04:19 A large adenoma and a ﬁne needle aspiration.
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04:20–04:42 A rare ﬁnding is the adrenal gland cyst. Possible
differential diagnoses are cystic tumors like the
rare cystic pheochromocytoma, pancreatic tail
pseudocysts and renal cysts.
04:43–05:21 This is an adenoma in Cushing’s disease.
05:22–05:31 Calciﬁcations are frequent after infections.
05:32–05:41 Typically, pheochromocytoma are large,
hypervascular and heterogeneous tumors with
regressive changes.
05:42–05:49 Small pheochromocytoma or adrenocortical
adenoma?
05:50–06:13 A rare diagnosis is the hyperechoic
angiomyolipoma which usually has a smooth
contour.
06:14–06:26 Renal cell carcinoma is highly metastatic – this is an
example of left adrenal gland metastasis of renal
cancer.
06:27–06:45 EUS-guided FNA of the adrenal glands is a
minimally invasive and safe approach that
documents or excludes malignant involvement
with high accuracy.
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